The administration of G-CSF has been found to ameliorate neutropenia manifestations through its ability to promote neutrophil progenitor cell proliferation and increase the activity of fully differentiated neutrophils [47]. The gene discussed is CSF3; the disease is Decreased total neutrophil count.